| The role of the pathologist in the next-generation era of tumor molecular characterization V Angerilli, F Galuppini, F Pagni, N Fusco, U Malapelle, M Fassan Diagnostics 11 (2), 339, 2021 | 56 | 2021 |
| The immunopathological and histological landscape of COVID-19-mediated lung injury G Zarrilli, V Angerilli, G Businello, M Sbaraglia, G Traverso, F Fortarezza, ... International Journal of Molecular Sciences 22 (2), 974, 2021 | 35 | 2021 |
| PD-L1 expression in gastroesophageal dysplastic lesions M Fassan, S Brignola, G Pennelli, G Alberti, V Angerilli, A Bressan, ... Virchows Archiv 477, 151-156, 2020 | 26 | 2020 |
| Prognostic impact of FGFR2/3 alterations in patients with biliary tract cancers receiving systemic chemotherapy: the BITCOIN study M Rizzato, S Brignola, G Munari, M Gatti, V Dadduzio, C Borga, ... European Journal of Cancer 166, 165-175, 2022 | 19 | 2022 |
| FFPE-based NGS approaches into clinical practice: The limits of glory from a pathologist viewpoint F Cappello, V Angerilli, G Munari, C Ceccon, M Sabbadin, F Pagni, ... Journal of Personalized Medicine 12 (5), 750, 2022 | 17 | 2022 |
| Molecular landscapes of gastric pre-neoplastic and pre-invasive lesions G Businello, V Angerilli, P Parente, S Realdon, E Savarino, F Farinati, ... International Journal of Molecular Sciences 22 (18), 9950, 2021 | 17 | 2021 |
| miRNAs involved in esophageal carcinogenesis and miRNA-related therapeutic perspectives in esophageal carcinoma G Zarrilli, F Galuppini, V Angerilli, G Munari, M Sabbadin, V Lazzarin, ... International journal of molecular sciences 22 (7), 3640, 2021 | 16 | 2021 |
| Tumour mutational burden predicts resistance to EGFR/BRAF blockade in BRAF-mutated microsatellite stable metastatic colorectal cancer G Randon, R Intini, C Cremolini, E Elez, MJ Overman, J Lee, P Manca, ... European Journal of Cancer 161, 90-98, 2022 | 15 | 2022 |
| PD-L1 evaluation in the gastrointestinal tract: from biological rationale to its clinical application L Mastracci, F Grillo, P Parente, I Gullo, M Campora, V Angerilli, C Rossi, ... Pathologica 114 (5), 352, 2022 | 14 | 2022 |
| Comprehensive genomic profiling (CGP)-informed personalized molecular residual disease (MRD) detection: an exploratory analysis from the PREDATOR study of metastatic colorectal … S Lonardi, H Nimeiri, C Xu, DR Zollinger, RW Madison, AD Fine, ... International Journal of Molecular Sciences 23 (19), 11529, 2022 | 14 | 2022 |
| BRAF-mutated colorectal adenocarcinomas: Pathological heterogeneity and clinical implications V Angerilli, G Sabella, G Centonze, S Lonardi, F Bergamo, A Mangogna, ... Critical Reviews in Oncology/Hematology 172, 103647, 2022 | 13 | 2022 |
| The day-to-day practice of MMR and MSI assessment in colorectal adenocarcinoma: what we know and what we still need to explore P Parente, F Grillo, A Vanoli, MC Macciomei, MR Ambrosio, N Scibetta, ... Dig Dis 1 (10.1159), 000531003, 2023 | 8 | 2023 |
| MicroRNAs as predictive biomarkers of resistance to targeted therapies in gastrointestinal tumors V Angerilli, F Galuppini, G Businello, L Dal Santo, E Savarino, S Realdon, ... Biomedicines 9 (3), 318, 2021 | 8 | 2021 |
| Evaluating mismatch repair deficiency in colorectal cancer biopsy specimens F Grillo, M Paudice, A Gambella, S Bozzano, S Sciallero, A Puccini, ... Histochemistry and Cell Biology 160 (2), 113-125, 2023 | 7 | 2023 |
| A real-world application of liquid biopsy in metastatic colorectal cancer: the Poseidon study L Procaccio, F Bergamo, F Daniel, C Rasola, G Munari, P Biason, ... Cancers 13 (20), 5128, 2021 | 7 | 2021 |
| MMR profile and microsatellite instability status in colorectal mucinous adenocarcinoma with synchronous metastasis: a new clue for the clinical practice P Parente, U Malapelle, V Angerilli, M Balistreri, S Lonardi, S Pucciarelli, ... Journal of Clinical Pathology 76 (7), 492-496, 2023 | 6 | 2023 |
| Claudin-18 expression in small bowel adenocarcinoma: a clinico-pathologic study G Arpa, M Fassan, C Guerini, E Quaquarini, F Grillo, V Angerilli, ... Virchows Archiv 481 (6), 853-863, 2022 | 6 | 2022 |
| Multi-design differential expression profiling of COVID-19 lung autopsy specimens reveals significantly deregulated inflammatory pathways and sftpc impaired transcription M Fassan, A Collesei, V Angerilli, M Sbaraglia, F Fortarezza, F Pezzuto, ... Cells 11 (6), 1011, 2022 | 6 | 2022 |
| Current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter G Businello, V Angerilli, S Lonardi, F Bergamo, M Valmasoni, F Farinati, ... Updates in Surgery 75 (2), 291-303, 2023 | 5 | 2023 |
| Microsatellite instable colorectal adenocarcinoma diagnostics: the advent of liquid biopsy approaches C Ceccon, V Angerilli, C Rasola, L Procaccio, M Sabbadin, F Bergamo, ... Frontiers in Oncology 12, 930108, 2022 | 5 | 2022 |
